Healthcare is advancing more swiftly by the year with new technologies, treatment options and artificial intelligence models hitting hospitals across the world. With the acceleration of advancements, it is hard to imagine how the industry will change. While some believe racial equity challenges might remain, others expect personalized care by genomics to be the standard and that there will be medications that will prevent disease before it takes root. Becker’s asked eight leaders to speculate on what healthcare might look like in 2123: Tony Ambrozie. Senior Vice President and Chief Digital and Information Officer of Baptist Health South Florida (Coral…
Author: Abhay Panchal
June 2 (Reuters) – Cancer test maker Grail Inc (GRAL.O) said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer. Grail’s flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear. The company, owned by Illumina Inc (ILMN.O), said the letters were mistakenly sent by PWNHealth due to a software issue and that it “was in no way related to or caused by an incorrect Galleri test result”.
NEW YORK, June 5, 2023 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid Diagnostics” or “Lucid”), a commercial-stage cancer prevention diagnostics company and a majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ), today announced the launch of its first EsoGuard® #CheckYourFoodTube Mobile Test Unit serving patients and practices in the Greater Central Florida area. Florida Digestive Health Specialists (“FDHS”), Florida’s largest gastroenterology network, will co-host the inaugural precancer detection event at the Gastroenterology Associates of Sarasota offices in Sarasota, Florida under the direction of Dr. Scott Corbett, Chief of Gastroenterology at Sarasota Memorial Hospital.
June 5 (Reuters) – Akero Therapeutics Inc (AKRO.O) said on Monday data from a mid-stage study showed its experimental therapy reduced liver fat by 65% in certain patients with a type of fatty liver disease called nonalcoholic steatohepatitis (NASH). The drug, efruxifermin, also met secondary efficacy goals when tested alongside a diabetes treatment belonging to a class of drugs known as GLP-1 receptor agonists in the trial.
CHICAGO, June 6, 2023 /PRNewswire/ — Vivante Health, the leading provider of digital digestive health solutions, today announced that Chico’s FAS, Grifols and other prominent businesses have added Vivante’s GIThrive platform to their benefits packages to help employees manage debilitating digestive diseases as well as to reduce corporate medical spend. Chico’s FAS is the publicly traded fashion company that owns and operates the Chico’s, White House Black Market and Soma brands with 1,260 boutiques and outlets across the country. Grifols, a global healthcare company based in Spain that specializes in plasma-derived medicines and transfusion medicine, has 17,000 employees in the…
June 08, 2023 – Health insurer policies are increasing administrative burden for independent physician practices, pushing them to seek employment in other settings and fueling physician practice acquisitions, a report from the American Hospital Association (AHA) highlighted. The number of physician practices affiliated with hospitals and health systems has grown in recent years. Most of the discussions surrounding these acquisitions tend to focus on hospitals’ intentions and perspectives. The AHA report provides insight into physicians’ views and what may motivate them to turn to hospitals and health systems for continued employment.
KATY, TX / ACCESSWIRE / June 7, 2023 / Gastro Health & Nutrition is pleased to announce its third gastroenterology clinic opening this month. Building upon the success of its Victoria location, which has been serving the community for nearly a decade, Gastro Health & Nutrition now expands its presence to the Memorial City area of Houston. The team is now equipped with six provider groups to deliver digestive care to patients in the Victoria, Katy, and now, West Houston communities, as well as the surrounding areas. This collaboration addresses the growing demand for specialized gastrointestinal services in the region.…
Marpai adds industry-leading virtual multidisciplinary gastrointestinal care clinic to its value-based care network to improve member health and lower employer costs. NEW YORK, June 8, 2023 /PRNewswire/ — Marpai, Inc. (“Marpai” or the “Company”) (Nasdaq: MRAI), an AI-powered Third-Party Administrator (TPA) transforming self-funded employer health plans, announces a relationship with Oshi Health, Inc. (“Oshi Health” or “Oshi”) to offer the most clinically advanced virtual digestive care to its employer health plan members. The result of rigorous clinical evaluation, this relationship meets the increased urgency of employers to address digestive health concerns and provide access to multidisciplinary digestive care to their…
UnitedHealthcare halted its controversial prior authorization policy for gastroenterology endoscopy services, set to start on June 1, opting instead to move forward with an advanced notification program. Following widespread backlash from more than 4,500 gastroenterologists and patients, the insurance company announced it would postpone the prior authorization policy that would have affected more than 27 million of its beneficiaries. Instead, UnitedHealthcare plans to implement an advance notification process “for non-screening gastroenterology procedures” under its commercial plans.
AGA’s new Clinical Practice Update provides guidance for the diagnosis and management of extraesophageal gastroesophageal reflux disease (GERD). The guidance and associated clinical decision support tool focus on conditions suspected to have potential relationships to acid reflux and provide best approaches to diagnosis, evaluation and therapy.